Perspectives on Outsourcing

Mar 01, 2017
BioPharm International
Moving global manufacturing operations may be more complicated than it appears.
Feb 01, 2017
BioPharm International
The outlook for the CMO and CDMO industry may be affected by ever-changing politics.
Dec 01, 2016
BioPharm International
Biosimilars may be the key to CMO growth.
Nov 01, 2016
BioPharm International
CMO executives are focusing on M&A activity, new business models, and fundraising limits.
Oct 01, 2016
BioPharm International
This key bioprocessing segment is expecting continued growth.
Sep 01, 2016
BioPharm International
The strategies of a innovation-driven CMO may be different than a capacity-driven CMO.
Aug 01, 2016
BioPharm International
CMOs are working hard to improve performance by investigating new technologies for filtration and purification.
Jul 02, 2016
BioPharm International
CDMOs need to be aware that unfavorable public markets put emerging bio/pharma R&D spending at risk in 2017.
Jun 02, 2016
BioPharm International
Acquisition binges often lead to hangovers; here’s what to watch out for.
May 01, 2016
BioPharm International
Growth may be slowing, but outsourcing activity remains healthy.
native1_300x100
lorem ipsum